TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Inhalation Sciences Sweden AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,578
|
1,096
|
921 |
Financial expenses |
90
|
9
|
4 |
Earnings before taxes |
-428
|
-1,090
|
-1,624 |
EBITDA |
-238
|
-975
|
-1,505 |
Total assets |
1,637
|
1,167
|
2,553 |
Current assets |
1,423
|
853
|
2,101 |
Current liabilities |
430
|
411
|
495 |
Equity capital |
1,167
|
679
|
1,924 |
- share capital |
547
|
409
|
445 |
Employees (average) |
8
|
9
![]() |
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
71.3%
|
58.2%
|
75.4% |
Turnover per employee |
197
|
122
|
102 |
Profit as a percentage of turnover |
-27.1%
|
-99.5%
|
-176.3% |
Return on assets (ROA) |
-20.6%
|
-92.6%
|
-63.5% |
Current ratio |
330.9%
|
207.5%
|
424.4% |
Return on equity (ROE) |
-36.7%
|
-160.5%
|
-84.4% |
Change turnover |
479
|
249
|
-70 |
Change turnover % |
44%
|
29%
|
-7% |
Chg. No. of employees |
-1
|
0
|
1 |
Chg. No. of employees % |
-11%
|
0%
|
13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.